Does BELANTAMAB MAFODOTIN Cause Upper respiratory tract infection? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Upper respiratory tract infection have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 0.3% of all adverse event reports for BELANTAMAB MAFODOTIN.
7
Reports of Upper respiratory tract infection with BELANTAMAB MAFODOTIN
0.3%
of all BELANTAMAB MAFODOTIN reports
5
Deaths
1
Hospitalizations
How Dangerous Is Upper respiratory tract infection From BELANTAMAB MAFODOTIN?
Of the 7 reports, 5 (71.4%) resulted in death, 1 (14.3%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for BELANTAMAB MAFODOTIN.
What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?
Keratopathy (788)
Visual acuity reduced (708)
Death (499)
Plasma cell myeloma (380)
Dry eye (359)
Night blindness (317)
Photophobia (183)
Foreign body sensation in eyes (151)
Vision blurred (134)
Ocular toxicity (94)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which BELANTAMAB MAFODOTIN Alternatives Have Lower Upper respiratory tract infection Risk?
BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF
BELANTAMAB MAFODOTIN vs BELATACEPT
BELANTAMAB MAFODOTIN vs BELIMUMAB
BELANTAMAB MAFODOTIN vs BELINOSTAT
BELANTAMAB MAFODOTIN vs BELUMOSUDIL